Drugs News and Research

RSS

Study shows polysaccharides of seaweed and abalone inhibit SARS-CoV-2 in vitro

A new study published in Marine Drugs evaluated the inhibitory effect of three polysaccharides, crude polysaccharide from Hizikia fusiforme (CPHF), crude polysaccharide from Sargassum horneri (CPSH), and crude polysaccharide from abalone viscera (CPAV) on the propagation of SARS-CoV-2 in vitro.

28 Apr 2022

Yale researchers identify immune system culprit in severe COVID cases

Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.

28 Apr 2022

Study offers critical clues into longstanding mystery of deep sleep

Healthy sleep is a basic physiologic need. In its absence, a myriad of processes in the body can go terribly awry. Chronic sleep problems have been linked to mental health disorders, cardiovascular disease, type 2 diabetes, and obesity, among other conditions.

28 Apr 2022

Tufts scientists discover a previously unknown function performed by astrocytes

Researchers at Tufts University School of Medicine have discovered a previously unknown function performed by a type of cell that comprises nearly half of all cells in the brain.

28 Apr 2022

New study predicts which hospitalized COVID-19 patients are at high risk for severe disease

A just-published study provides previously unknown answers about which hospitalized COVID-19 patients are most likely to need mechanical ventilation or to die.

28 Apr 2022

The added value of adequate immune fitness to the existing approaches to pandemic preparedness

Researchers described two studies, the CLOFIT retrospective study and the COTEST real-time study, that investigated if maintaining adequate immune fitness could significantly add to the current strategies of preparedness for COVID-19 and other pandemics.

28 Apr 2022

Sen. Orrin Hatch’s legacy tracks the GOP’s evolution on health

When it comes to health policy, former Utah Republican Sen. Orrin Hatch, who died April 23 at age 88, leaves a complex legacy of major legislative achievements, changing positions, compromises, and fierce opposition.

28 Apr 2022

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell growth, can also make the cancer vulnerable.

28 Apr 2022

Synthetic data accurately replicates the results of analyses from real COVID-19 patient data

Research led by Washington University School of Medicine in St. Louis has demonstrated that analyzing synthetic data generated from real COVID-19 patients accurately replicates the results of the same analyses conducted on the real patient data.

27 Apr 2022

Novel plug-and-play multi-organ chip can be customized to the patient

Engineered tissues have become a critical component for modeling diseases and testing the efficacy and safety of drugs in a human context.

27 Apr 2022

Combination therapy shows promise for treating triple-negative breast cancer

Researchers at Baylor College of Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) that results in durable tumor regression in an animal model of the condition.

27 Apr 2022

Gene discovery could pave the way for new and more effective treatments for lupus

Researchers from The Australian National University have identified a gene called TLR7 that, when over-activated, is responsible for causing lupus, an autoimmune disease that can be life-threatening in severe cases.

27 Apr 2022

MIT researchers develop a smarter method to discover new drugs

Pharmaceutical companies are using artificial intelligence to streamline the process of discovering new medicines.

27 Apr 2022

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, today unveiled Cancer Research Horizons, its new and ambitious approach to driving innovation in the development of new treatments for patients.

From Cancer Research UK 27 Apr 2022

Discovery about human cells’ stress response could deepen the understanding of various cancers

The communications line between two critical parts of a human cell could be the key to cell survival under stress - a discovery that could deepen our understanding of various cancers, according to new research from the University of Surrey.

26 Apr 2022

Well-established group of antimalarials unlikely to be affected by resistance, study shows

New research published today in Antimicrobial Agents and Chemotherapy, shows that the well-established group of antimalarials, known as artemisinins, are unlikely to be affected by resistance.

26 Apr 2022

Roswell Park experts to share latest advances in the treatment of blood-related cancers

Roswell Park Comprehensive Cancer Center specialists will share the latest advances and developments in the treatment of blood-related cancers at the 2022 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, Utah, from April 23 to 26.

26 Apr 2022

New discovery about nature’s ‘high-end machinery’ could have big implications for biology

Working with tiny bacteria, Michigan State University researchers led by Lee Kroos have made a discovery that could have big implications for biology.

26 Apr 2022

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

The Johns Hopkins Kimmel Cancer Center and the Departments of Gynecology/Obstetrics, Neurosurgery and Pathology have been awarded more than $7.8 million for novel, multicenter projects designed to intercept and find cures for several deadly cancers, including pancreatic cancer, ovarian cancer, and the brain cancer known as glioblastoma.

26 Apr 2022

Talking therapies could be effective for treating depression in people with dementia

Feelings of anxiety and depression are common in people living with dementia and mild cognitive impairment, but the best way to treat these symptoms is currently unknown, as medicines often used to treat these symptoms may not be effective for people with dementia and may cause side effects.

26 Apr 2022

Drugs News and Research

Study shows polysaccharides of seaweed and abalone inhibit SARS-CoV-2 in vitro

Yale researchers identify immune system culprit in severe COVID cases

Study offers critical clues into longstanding mystery of deep sleep

Tufts scientists discover a previously unknown function performed by astrocytes

New study predicts which hospitalized COVID-19 patients are at high risk for severe disease

The added value of adequate immune fitness to the existing approaches to pandemic preparedness

Sen. Orrin Hatch’s legacy tracks the GOP’s evolution on health

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

Synthetic data accurately replicates the results of analyses from real COVID-19 patient data

Novel plug-and-play multi-organ chip can be customized to the patient

Combination therapy shows promise for treating triple-negative breast cancer

Gene discovery could pave the way for new and more effective treatments for lupus

MIT researchers develop a smarter method to discover new drugs

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Discovery about human cells’ stress response could deepen the understanding of various cancers

Well-established group of antimalarials unlikely to be affected by resistance, study shows

Roswell Park experts to share latest advances in the treatment of blood-related cancers

New discovery about nature’s ‘high-end machinery’ could have big implications for biology

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

Talking therapies could be effective for treating depression in people with dementia

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News